Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-243
Acipimox
Cat. No.
AKA-243
CAS No.
51037-30-0
MF
C6H6N2O3
MW
154.12
Acipimox is a nicotinic acid analogue that inhibits lipolysis.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Acipimox
CAS No.
51037-30-0
MF
C6H6N2O3
MW
154.12
Specification
98%
Research Area
Inhibitor of Beta adrenergic receptor
Description
Acipimox is a nicotinic acid analogue that inhibits lipolysis. Packing: 1kg/bag; 25kg/drum or as request Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Vestergaard ET, et al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. British Journal of Clinical Pharmacology. 2017 Dec;83(12):2671-2677.
[2]. Wang-Fisher YL, et al. Acipimox stimulates leptin production from isolated rat adipocytes. The Journal of Endocrinology. 2002 Aug;174(2):267-72.
[3]. Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiologica Scandinavica. 2001 Feb;171(2):161-7.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
